[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August 9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 Net revenues were]
[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August 9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 Net revenues were]
[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]
[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]
[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]
[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]
[FORM 10−Q (Mark One) x For the quarterly period ended: June 30, 2010 ¨ For the transition period from ____________ to _____________ CHINA BAK BATTERY, INC. Nevad a 88-0442833 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) BAK Industrial Park No. 1 BAK Street Kuichong Town, Longgang District Shenzhen 518119 People’s Republic of China (86-755) 8977-0093] [CERTIFICATIONS I, Xiangqian Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Jun Zou, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 Xiangqian Li Chief Executive Officer EX-32.1 5 v192577_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 Jun Zou Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 v192577_ex32-2.htm] [Comprehensive Credit Facility Agreement of Maximum Amount (“ Credit Facility Agreement” ) Entered into by and between Shenzhen BAK Battery Co., Ltd ( the “ Company ” ) and Shenzhen Longgang Branch, Guangdong Development Bank ( the “ Creditor” ) Dated May 1 4 th , 20 10 Main contents Ø Contract number: 10204110099; Ø Maximum amount of credit facilities] [Comprehensive Credit Facility Agreement of Maximum Amount (“ Credit Facility Agreement” ) Entered into by and between Shenzhen BAK Battery Co., Ltd ( “ the Debtor ” ) and Shenzhen Branch, China Citic Bank ( the “ Creditor” ) Dated May 1 2 th , 20 10 Main articles: Ø Contract number: (2010) Shenyinsun Zongzi 004; Ø Maximum amount of] [Summary of Loan Agreement Entered into by and between Shenzhen BAK Battery Co., Ltd. (“the Company”) and Shenzhen Branch, China CITIC Bank Co., Ltd (“the Creditor”) dated June 11, 2010 Main contents Ø Contract number: (2010) Shenyinsun daizi 015; Ø Loan principal: RMB 40 million; Ø Loan term: from June 11, 2010 to June 11, 2011; Ø Floating interest rate:] [Summary of Loan Agreement Entered into by and between Shenzhen BAK Battery Co., Ltd. (“the Company”) and Shenzhen Branch, China CITIC Bank Co., Ltd (“the Creditor”) dated June 11, 2010 Main contents Ø Contract number: (2010) Shenyinsun daizi 013; Ø Loan principal: RMB 40 million; Ø Loan term: from June 11, 2010 to June 11, 2011; Ø Floating interest rate:] [Summary of Guaranty Contract of Maximum Amount ( the “Contract”) Entered into by and between Xiangqian Li and Shenzhen Branch, China Citic Bank (the “Creditor”) on May 31, 2010 Main contents: Ø Ø Ø Ø Guaran t y Responsibility Ø S cope of G uaranty: Ø Guaranty period: Headlines of the articles omitted: Ø Ø Ø Ø Ø Ø Ø] [Summary of Guaranty Contract of Maximum Amount ( the “Contract”) Entered into by and between BAK International Limited and Shenzhen Branch, China Citic Bank (the “Creditor”) in May 12, 2010 Main contents: Ø Ø Ø Guarant y Responsibility Ø S cope of G uaranty: Ø Guaranty period: Headlines of the articles omitted: Ø Ø Ø Ø Ø Ø Ø Ø] [Summary of Loan Agreement Entered into by and between Shenzhen BAK Battery Co., Ltd. (“the Company”) and Shenzhen Eastern Branch, Agricultural Bank of China (“the Creditor”) dated May 21, 2010 Main contents Ø Contract number: 81101201000000603; Ø Loan principal: RMB 75 million; Ø Loan term: from May 21, 2010 to April 22, 2011; Ø Floating interest rate: annually 5.0445%, rate] [Summary of Loan Agreement Entered into by and between Shenzhen BAK Battery Co., Ltd. (“the Company”) and Shenzhen Eastern Branch, Agricultural Bank of China (“the Creditor”) dated May 19, 2010 Main contents Ø Contract number: 81101201000000590; Ø Loan principal: RMB 60 million; Ø Loan term: from May 19, 2010 to April 20, 2011; Ø Floating interest rate: annually 5.0445%, rate] [Summary of Loan Agreement Entered into by and between Shenzhen BAK Battery Co., Ltd. (“the Company”) and Shenzhen Eastern Branch, Agricultural Bank of China (“the Creditor”) dated May 17, 2010 Main contents Ø Contract number: 81101201000000575; Ø Loan principal: RMB 90 million; Ø Loan term: from May 17, 2010 to April 19, 2011; Ø Floating interest rate: annually 5.0445%, rate] [Summary of Loan Agreement Entered into by and between BAK International (Tianjin) Limited (“the Company”) and Tianjin Branch, Bank of Dalian (“the Creditor”) dated April 27, 2010 Main contents Ø Contract number: DLLJin 201006300077; Ø Loan principal: RMB 20 million; Ø Loan term: from April 27, 2009 to November 26, 2010; Ø Floating interest rate: annually 5.5755%, rate adjustment in]
[Synutra Reports First Quarter 2011 Financial Results 1Q11 Net Sales Up 77.0% to $83.8 Million from the Prior Year Period 1Q11 Net Income of $10.1 Million, or $0.19 per Diluted Share Qingdao, China and Rockville, Md. – August 9, 2010 -- First Quarter Fiscal 2011 Financial Highlights • Net sales up 77.0% to $83.8 million from $47.4 million in the] []
[Note: X Yes Not applicable]
[Hollysys Automation Technologies Provides Its Ground-Based High-Speed Rail Signaling System to Hankou-Yichang and Xiamen-Shenzhen Lines Beijing, China – Aug 9, 2010 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) (“Hollysys” or the “Company”), Line Side Electronic Units (LEU) Dr. Changli Wang, Hollysys’ CEO and Chairman of the Board, commented, “We are very pleased to sign the two contracts to provide our]
